22JPM

Haisco Pharmaceutical to Participate at ACCESS CHINA Biotech Forum

By Yafo Life Sciences

December 28th, 2021 (Shanghai) — We are glad to announce that Arya Liu, the BD Senior Manager of Haisco Pharmaceutical, has been invited to showcase at ACCESS CHINA Biotech Forum during Jan 4th – Jan13th. ACCESS CHINA Biotech Forum is the largest online corporate access event between China and the western biopharma industry.

If you are interested in listening to the live event, please register at https://biotochina.org/register/

About Haisco Pharmaceutical

Haisco Pharmaceutical Group, founded in 2000, has business in new drug development, manufacturing and sales .Haisco is dedicated to developing and supplying the best medicine to protect the health and wellbeing of the patients we serve, and aspires to become a mostly trusted leading enterprise in medical and healthcare industry. Haisco has 15 NCEs in the pipeline in the field of Anesthesia, Pain and Oncology, and 3 proprietary technology platfroms. Haisco was listed on the Shenzhen Stock Exchange in 2012. In 2017, Haisco established its R&D centers in the United States. The sales reached over 500 million dollars in 2020.

About the speaker

Arya Liu, MSc. International Health.
BSc. Pharmaceutical Science, BD Senior Manager in Haisco Pharmaceutical Group. 7 years Industry experience, experience of multiple license-in & out,co-development projects

About ACCESS CHINA

ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations. View more information at https://biotochina.org/access-china-forum/


Contact US

Register ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum

For more information, please contact:

Wendi Xiang

Wxiang@yafocapital.com